Capital Fund Management S.A. Ultragenyx Pharmaceutical Inc. Transaction History
Capital Fund Management S.A.
- $37.9 Billion
- Q4 2024
A detailed history of Capital Fund Management S.A. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 34,225 shares of RARE stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,225
Previous 36,511
6.26%
Holding current value
$1.32 Million
Previous $2.03 Million
29.04%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
345Shares Held
86.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$388 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$216 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$166 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$105 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$97 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.7B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...